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Summary
Many inherited cancer-prone conditions show an ele-
vated sensitivity to the induction of chromosome dam-
age in cells exposed to ionizing radiation, indicative of
defects in the processing of DNA damage. We earlier
found that 40% of patients with breast cancer and
5%–10% of controls showed evidence of enhanced
chromosomal radiosensitivity and that this sensitivity
was not age related. We suggested that this could be a
marker of cancer-predisposing genes of low penetrance.
To further test this hypothesis, we have studied the her-
itability of radiosensitivity in families of patients with
breast cancer. Of 37 first-degree relatives of 16 sensitive
patients, 23 (62%) were themselves sensitive, compared
with 1 (7%) of 15 first-degree relatives of four patients
with normal responses. The distribution of radiosensi-
tivities among the family members showed a trimodal
distribution, suggesting the presence of a limited number
of major genes determining radiosensitivity. Segregation
analysis of 95 family members showed clear evidence of
heritability of radiosensitivity, with a single major gene
accounting for 82% of the variance between family
members. The two alleles combine in an additive (co-
dominant) manner, giving complete heterozygote ex-
pression. A better fit was obtained to a model that in-
cludes a second, rarer gene with a similar, additive effect
on radiosensitivity, but the data are clearly consistent
with a range of models. Novel genes involved in pre-
disposition to breast cancer can now be sought through
linkage studies using this quantitative trait.
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Introduction
A clear association between cancer predisposition and
the hypersensitivity of cells to ionizing radiation (Taylor
et al. 1975) was first demonstrated for patients with the
recessively inherited multisystem disorder ataxia-telan-
giectasia (A-T [MIM 208900]). Assays of radiation-in-
duced chromosome damage showed the greatest dis-
crimination between A-T patients and normal controls
(Taylor 1983). In such assays, 20 other inherited cancer-
prone conditions have been shown to exhibit some de-
gree of elevated chromosomal radiosensitivity (Scott et
al. 1999). This suggests that defects in the processing of
DNA damage of the type induced by ionizing radiation
could contribute to cancer predisposition in these rare
conditions. Among these in which the underlying gene
has been identified, the most prevalent are A-T hetero-
zygotes, estimated to constitute ∼0.5% of the population
and to have a fourfold-increased relative risk of breast
cancer (Easton 1994). It has been estimated that ∼4%
(Easton 1994), but up to 18% (Swift et al. 1987), of all
cases of breast cancer could be A-T–gene carriers. In an
attempt to identify these on the basis of their enhanced
chromosomal radiosensitivity, we tested an unselected
series of patients with breast cancer, by irradiating lym-
phocytes in the G2 phase of the cell cycle (Scott et al.
1994, 1999). We found that 42% (57/135) were sensi-
tive, compared with 6% (6/105) of healthy controls (fig.
1). Clearly, there must be factors other than A-T
heterozygosity that contribute to chromosomal radio-
sensitivity among cases of breast cancer and among con-
trols. We postulated that other low-penetrance predis-
posing genes could be responsible. We found that age
at diagnosis had no influence on radiosensitivity, sug-
gesting that the putative genes result in a normal age at
onset of breast cancer, as has been reported for A-T
heterozygotes (Athma et al. 1996). Increased G2 chro-
mosomal radiosensitivity of cases of breast cancer, com-
pared with controls, has now been confirmed in two
independent studies (Parshad et al. 1996; Patel et al.
1997).
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Figure 1 Yields of radiation-induced chromosomal aberrations
in lymphocytes exposed to 0.5-Gy x-rays in the G2 phase of the cell
cycle. Top, Normal healthy donors. Bottom, Patients with breast can-
cer. The vertical dashed line indicates the cutoff point between a normal
and a sensitive response. Data are from Scott et al. (1999).
The major highly penetrant genes that predispose to
breast cancer—and that typically lead to a strong family
history of the disease—are BRCA1 and BRCA2 (Ford
et al. 1998). These genes have a role in DNA repair after
exposure of cells to ionizing radiation (Kinzler and Vo-
gelstein 1997). Another high-penetrance predisposing
gene is TP53, associated with the cancer-prone Li-Frau-
meni syndrome (Varley et al. 1997). However, !5% of
cases of breast cancer will be associated with mutations
in any of these three genes (Goldgar et al. 1996). The
concept that, in addition to these highly expressed genes,
there are other, low-penetrance genes predisposing to
breast cancer in a substantial proportion of cases is sup-
ported by epidemiological investigations (Teare et al.
1994; Ford et al. 1998). Our results suggest that among
these low-penetrance genes are those involved in the pro-
cessing of DNA damage (International Commission on
Radiation Protection 1999) and that these, when defec-
tive, lead to enhanced chromosomal radiosensitivity. A
small proportion of these may be mutant ATM genes in
heterozygotes, although recent findings suggest that the
frequency ofATMmutations among patients with breast
cancer may be considerably lower than early estimates
(Swift et al. 1987; Bishop and Hopper 1997).
Our hypothesis would be considerably strengthened
if it could be shown that chromosomal radiosensitivity
is an inherited characteristic in families of patients with
breast cancer. Here we report the results of such an
investigation.
Subjects and Methods
Patients and Families
Families were selected on the basis of the following
criteria: (1) the level of chromosomal radiosensitivity of
the patient with cancer (the index case) within the family,
established on the basis of our previous study (Scott et
al. 1999), was used to select the 16 most sensitive index
cases who met the remaining criteria, as well as an ad-
ditional 4 index cases with aberration yields close to the
modal value of the historic controls; (2) the residence of
family members was within a reasonable distance of our
institute, so that blood samples could be taken in their
homes and transported to our institute by our phlebot-
omist (this was to avoid transportation of samples from
distant sources by courier, because poor reproducibility
of results has occasionally been obtained from such sam-
ples) (Scott et al. 1999); (3) the patients were willing to
participate in the study; and (4) the patients were alive
and well and had at least one first-degree relative willing
and able to participate. All these studies were performed
with the approval of the South Manchester Health Au-
thority Ethical Committee.
Tests were done on 60 blood relatives of 20 index
cases during a period of 2 years, on 51 different occa-
sions, with two to eight blood samples being tested on
each occasion. Index cases were questioned about oc-
currences of breast and other cancers within their fam-
ilies, but no attempt was made to confirm this infor-
mation, since it was not our intention within this study
to obtain detailed estimates of familial cancer risk (see
the Discussion section, below). Much larger population-
or family-based case/control studies would be required
for this purpose. Expected numbers of breast cancer
cases were derived from regional cancer statistics.
In total, 43 healthy controls were also tested. These
comprised 25 “traveling” controls, whose blood samples
accompanied the samples from family members, and 18
“local” controls, from donors in our institute. The trav-
eling samples were included to control for the possibility
that transportation of samples over relatively short dis-
tances in this study might introduce the problems of
reproducibility that have been noted above. Fifteen of
the traveling controls were spouses of family members
and thus contribute to the study both as nonblood-rel-
ative controls and as members of the pedigrees for ge-
netic analysis. Some of the local controls donated blood
samples on several (up to nine) occasions. All index cases
had previously been tested before radiotherapy was ad-
ministered. The majority (18/20) were retested 5–39 mo
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after therapy; 2 patients were retested twice. Six blood
relatives were tested on more than one occasion. A total
of 164 samples were tested in this study.
Methods
The assay.—Full details of the methods used in this
study are given in the work of Scott et al. (1999). In
brief, cultures of whole blood were established !24 h
after blood was drawn, and lymphocytes were stimu-
lated to proliferate with the mitogen, phytohemagglu-
tinin. At 72 h poststimulation, cells were exposed to 0.5-
Gy x-rays or were sham irradiated. At 30 min after
irradiation, colcemid was added for 60 min, to arrest
cells at metaphase that were in the G2 phase at the time
of irradiation. Harvesting procedures, including hypo-
tonic treatment, were all performed at 4C. For analysis,
slides were coded and randomized; 50 metaphases from
each sample were analyzed for chromosomal damage
(mainly chromatid gaps and breaks). The low yields of
aberrations seen in unirradiated cells (0–14/100 cells,
the highest values being found in postradiotherapy pa-
tients) were subtracted from those in irradiated cells of
each sample, to give the radiation-induced yields.
Statistical analysis.—The distribution of aberration
yields among the family members was fitted to a mixture
model based on lognormal distributions, by direct max-
imization of the log likelihood (commingling analysis).
The index cases and controls were excluded, since they
potentially form diverse populations that may bias the
analysis. In total, 78 family members were used in this
analysis, comprising the 60 blood relatives and 18 non-
blood relatives ascertained through the index cases.
Models consisting of one to four lognormal distributions
were considered, fitting a common variance parameter,
and the significance of extra components was assessed
by standard likelihood-ratio tests. Adding the index
cases and control individuals and/or allowing different
variances for the distributions gave essentially identical
results.
To investigate possible genetic mechanisms that might
be compatible with the data, we performed a segregation
analysis (Morton and McLean 1974). A log transfor-
mation was applied to the data, on the basis of the ob-
served distribution of values. The pretherapy aberration
yields were used for the index cases, along with the mean
values when there were repeat samples from the re-
maining individuals. A nested series of mixed (major
gene plus polygenic background) models was consid-
ered, the full mixed model containing a single locus with
two alleles and a residual Gaussian variance. This re-
sidual variance was partitioned into heritable and non-
heritable components, with the heritability parameter
(H), the ratio of the two variance components, having
values between 0 (no polygenic heritability) and 1. The
nonheritable (random) component is usually attributed
to environmental effects; however, in the present study,
with its inherent assay error, we might expect the ran-
dom component to be dominated by the assay error.
Simpler Mendelian models with either the major gene
alone or solely polygenic effects were compared with the
full mixed model. Two nonhereditary models were also
considered, a polygene-only model with no heritability
( ; i.e., a simple Gaussian model) and a generalH = 0
transmission (major environmental) model, with gene
transmission probabilities equal to the gene frequencies
(essentially the model used in the commingling analysis
discussed above). Finally, models with non-Mendelian
transmission were considered, in which the allele-trans-
mission probabilities for the major locus (t1, t2, and t3)
were allowed to vary from their Mendelian values of
, , and (Elston and Stewart 1971).t = 1 t = .5 t = 01 2 3
First, we considered relaxing the constraint that t = .52
and then considered a model in which all three trans-
mission parameters were fitted to the data. These models
provide a test for Mendelian segregation, and their use
provides a safeguard against falsely imputing a genetic
mechanism in situations in which the assumptions of the
model (particularly normality) are violated (Demenais
et al. 1986). Rejection of the Mendelian-transmission
parameters indicates either that there is a more complex
genetic mechanism, that the assumptions of the model
are violated, or that the apparent major-locus effect is
in fact a consequence of non-Mendelian commingling.
Harvey-Weinberg equilibrium was assumed, and
equal variances were fitted for each genotype. Likeli-
hoods were conditioned on the probands, to allow for
ascertainment bias, under the assumption of an approx-
imation to single selection (Thompson and Cannings
1979).
Models were compared with the full mixed model by
standard likelihood-ratio tests, and models that proved
to be a significantly worse fit to the data than was the
full model were rejected. The model with the fewest pa-
rameters not rejected by this comparison was then ac-
cepted as the most parsimonious model consistent with
the data. Analyses were performed by means of the PAP
package, version 4.0 (Hasstedt and Cartwright 1981),
subroutines papfqhw, paptctp or paptcms, papprmv,
papwgvc (Hasstedt 1993), papenqa, and papcrqa.
Since all the single-gene models showed an excess of
individuals with large residual deviations from the ob-
served phenotypic values, an additional model with two
major biallelic genes and no polygenic background was
considered as the simplestMendelianmodel representing
a more complex genetic basis. This was compared with
both the full model and the accepted, most parsimonious
model, by likelihood-ratio tests. In view of the com-
plexity of two-locus models (with nine genotypes, only
six of which are likely to be represented in the data set),
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Table 1
Assay Reproducibility of Local and Transported Samples, Assessed on the Basis of the
Intraindividual Variability in Aberration Yields of Repeated Samples
No. of
Individuals
(Samples)
Mean  SD (CV) of
Raw Aberration Yield Log-Transformed SD
Traveling samplesa 10 (20) 129.7  8.5 (6.5%) .076
Local controls 8 (25) 90.2  6.3 (7.0%) .070
All samples 18 (45) 107.7  7.2 (6.6%) .072
a Repeat samples from six blood relatives of index cases, one spouse, and two index cases tested
twice posttherapy; pretherapy samples were not included.
it is not practicable (nor would it be very informative)
to consider the equivalent mixed and non-Mendelian
models in a two-gene framework.
Results
Our earlier study of 135 patients and 105 controls
showed evidence of an overlapping bimodal distribution
of radiosensitivity values, with a value of 110 chro-
mosome aberrations/100 cells at the point of overlap
(Scott et al. 1999). This was used as the cutoff point
between a normal and a sensitive response (fig. 1). Of
the 20 index cases selected, 16 were shown to be sensitive
in the test; 45 of their blood relatives were studied. Four
patients with a normal response were also selected, and
15 of their blood relatives were tested.
Assay Reproducibility
As a measure of assay reproducibility in our earlier
studies, we performed repeat tests on 28 local controls
(99 samples) and obtained a coefficient of variation (CV)
of 7% for intraindividual variability (Scott et al. 1999).
To test for any possible influence of transportation on
assay reproducibility in the present study, we compared
the intraindividual CV of eight local controls (25 sam-
ples) with that of transported samples from 10 family
members (20 samples). The CVs were computed on the
basis of a one-way analysis of variance. Both groups had
CVs of ∼7% (table 1), with no significant difference
between them ( ; variance-ratio F-test on log-P = .36
transformed data).
To test for any effect of radiotherapy on radiosensi-
tivity, we compared pre- and posttherapy values in 18
index cases (table 2). There was no significant difference
( ; Wilcoxon signed-rank test).P = .81
Sensitivity of Family Members
Results of tests for radiosensitivity are summarized in
table 2. The mean sensitivity of the 45 blood relatives
of the 16 sensitive index cases was intermediate between
that of the controls and that of the patients and was
significantly different from both ( for both com-P ! .001
parisons, byMann-Whitney U-tests). On the other hand,
the 15 first-degree relatives of the four patients with a
normal response had an average sensitivity similar to
that of the patients and controls. When the sensitivity
cutoff value of 110 was used, 62% (23/37) of the first-
degree relatives of sensitive patients were also sensitive
(fig. 2), compared with only 7% (1/15) of first-degree
relatives of normal patients ( , by Fisher’s exactP ! .001
test). One (2%) of the 43 controls was reproducibly
sensitive (fig. 2). Four of eight second-degree relatives of
sensitive patients were also sensitive.
The distribution of radiosensitivities among the 78
family members (excluding index cases) is shown in fig-
ure 3. Using maximum-likelihoodmethodology, we have
fitted this distribution to a sum of lognormal distribu-
tions (a mixture model or commingling analysis), using
a common variance for each peak. We can discern three
statistically significant populations within the data, with
means of 88.2, 122.7, and 175.9 and with a common
CV of 7.8% (fig. 3). The width of the peaks was only
marginally greater than the estimated 6%–7% variabil-
ity of the assay. The addition of a fourth peak was not
statistically significant ( ); neither was there anyP = .18
significant improvement in the fit when the distributions
were allowed to have different widths ( ). TheP = .26
proportion of the family members in each of the three
populations was 61%, 32%, and 7%, respectively.
Segregation of Sensitivity in Families
The increased radiosensitivity (i.e., above that in con-
trols) of healthy blood relatives supports the hypothesis
that the sensitivity has a genetic basis, and the trimodal
distribution of radiosensitivities within the families is
strongly suggestive of a major gene segregating within
the families. We have therefore performed a segregation
analysis on the pedigree data (95 individuals in 20 fam-
ilies; see pedigrees shown in fig. 4), to further investigate
the heritability of radiosensitivity and to elucidate po-
tential genetic mechanisms.
We consider a series of mixed genetic models con-
taining a major gene with two alleles (n and s) and an
additive polygenic background. Eight of the models
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Figure 2 Yields of radiation-induced chromosomal aberrations
in lymphocytes exposed to 0.5-Gy x-rays in the G2 phase of the cell
cycle. Top, Healthy controls tested in parallel with samples from the
families. The sensitive individual (to the right of the vertical dashed
line) was tested twice and gave values of 120 aberrations/cells and 126
aberrations/100 cells, respectively.Middle, Patients with breast cancer,
selected as being sensitive in the assay when tested before radiotherapy.
Bottom, First-degree relatives of the patients with breast cancer who
are shown in the middle panel.
Figure 3 Relative-density histogram of the distribution of the
mean G2 values of the 78 family members in the study (excluding
index cases). The line indicates the fitted density functions with three
log-normal peaks of equal width.
considered are shown in table 3. The model fits are
compared with that of the most general model of non-
Mendelian transmission of the three major phenotypes
and a polygenic component (model 1). The three models
that do not include a major-gene effect (models 3–5) are
clearly rejected. The two models that include a major
gene (models 2 and 6) cannot be rejected. The most
parsimonious of these two models is that with a single
gene only and no polygenes (model 2), and thus we
accept this as the simplest genetic model consistent with
the data. The addition of a polygenic component to this
model does not significantly improve the fit ( ).P = .11
Thus, the segregation analysis suggests that the data
can be reasonably well fitted by a single gene segregating
within these families and that this single gene is sufficient
to account for 82% of the variability in sensitivity be-
tween family members. The genotype means indicate
that the heterozygote, ns, has a phenotypic value very
close to half the difference between those of the two
homozygotes, nn and ss (albeit on a logarithmic
scale)—that is, there is no dominance, and the two alleles
combine additively. The two alleles act in a codominant
fashion with heterozygote expression (e.g., see family 1
in fig. 5). The difference between the nn and ss geno-
types, in units of the SD (often called the “displace-
ment”) is 7.8. This large displacement enables reason-
ably accurate genotype estimation and facilitates the
detection of major-gene effects in such a relatively small
sample. The residual SD of 0.10 is just a little larger
than the value of 0.072, which would be expected from
assay repeatability alone, although it does suggest an
additional environmental contribution to the variance,
of almost the same magnitude as the assay variability.
However, there were indications that the single-gene
genetic model was not adequate to explain the data fully
and that a more complex model was required. For read-
ers familiar with segregation analyses, the details of the
inadequacies are given in the next two paragraphs; the
general reader may safely ignore these details.
First, we tested whether the putative genes segregate
with frequencies consistent with Mendelian transmis-
sion; the single-gene model was compared with models
in which we relax the constraint that the transmission
probabilities t1, t2, and t3, for the three genotypes nn,
ns, and ss, respectively, take the values , ,t = 1 t = .51 2
and . The first test, often considered to be the mostt = 03
appropriate test for Mendelian inheritance (Lalouel et
al. 1983; Demenais et al. 1986), relaxes the constraint
that , and the fitted value obtained is ,t = .5 t = .352 2
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Table 2
Yields of Radiation-Induced Aberrations in the Various Groups, Proportions of Sensitive Cases,
and Significance Levels
Family Type and Category (No.)
Mean  SD Radiation-
Induced Aberration Yield
No. (%)
Sensitivea Significanceb
Sensitive proband:
Index cases:
Pretherapy (16) 142.8  19.5 16 (100)
Posttherapy (14) 144.9  20.2 13 (93)
Relatives:
All first degree (37) 115.4  29.2 23 (62) !.001
Parents (3) 114.7  25.3 2 (67) .11
Sibs (12) 129.6  27.2 11 (92) !.001
Children (22) 107.7  28.8 10 (45) .048
All second degree (8) 120.5  34.4 4 (50) .001
Normal proband:
Index cases:
Pretherapy (4) 91.5  5.0 0 (0)
Posttherapy (4) 91.5  5.3 0 (0)
Relatives:
All first degree (15) 88.3  9.6 1 (7) .20
Sibs (9) 90.7  11.0 1 (11) .60
Children (6) 84.7  6.4 0 (0) .13
Controls:
All (43) 90.3  8.0 1 (2)
Traveling (25) 89.5  9.1 1 (4)
Local (18) 91.5  6.5 0 (0)
a For a cutoff of 110 aberrations/100 cells.
b Comparison of aberration yields versus those in controls, by Mann-Whitney U-test.
which is not significantly different from the Mendelian
value ( ). However, a more stringent test, inP = .087
which all three transmission probabilities are unres-
tricted, yields an improvement to the fit, which just
achieves statistical significance ( ). This border-P = .045
line significance could indicate a true failure of Men-
delian inheritance, with a major environmental effect
leading to three phenotypes that segregate with non-
Mendelian probabilities. Given the significant trimodal
distribution of sensitivities, the wide separation of the
putative genotypes, and the underlying biology, this is
highly unlikely. Alternatively, the failure of the model to
pass the most stringent test of Mendelian inheritance
could be due to some residual skewness in the sensitivity
distributions following the logarithmic transformation
(Demenais et al. 1986) is calculated, but there is little
evidence of this (fig. 3). A more likely possibility is that
the inheritance is Mendelian, but with a more complex
genetic mechanism.
Second, examination of the residuals indicates a gen-
erally good fit to the single-gene model, in that most of
the predicted phenotypes are close to the values ob-
served; however, there were exceptions to this, most no-
tably in one family (family 8) in which a very sensitive
individual (who had repeated scores of 162 and 160)
with a normal spouse (who had a score of 88) has chil-
dren with scores of 162 and 182 (fig. 5). Since the spouse
is normal, on the basis of a single-gene model these chil-
dren must be heterozygous (mean score 128), 2.4 and
3.5 SDs, respectively, from the observed values. Similar
but less extreme examples are also found in three other
families (families 4, 6, and 15).
Thus, since there was some evidence of a lack of fit
to the single-gene model, and since there was already
one gene, ATM, known to convey a radiosensitive phe-
notype in a proportion of cases of breast cancer, we were
led to consider more-complex genetic models. Specifi-
cally, we considered amodel with twomajor genes,Men-
delian inheritance, and no polygenes. Surprisingly, this
model with seven extra parameters proved to be a
significantly better fit ( ) than2# log likelihood = 88.1
both our most-parsimonious single-gene model (table 3,
model 2; ) and the full general-transmissionP = .007
model (table 3, model 1; ). Thus, this modelP = .009
provides a significantly better explanation of the data
than does the single-gene model with non-Mendelian
transmission. The genotype means for this model are
given in table 4. With this model, the within-genotype
SD is 0.077, which is very close to the estimated assay
error; the residual error is thus entirely accounted for
by the assay error. Putative genotypes for family 8, for
the two-gene model, are given in figure 5.
The genotype means (table 4) indicate two genes with
similar phenotypic effects, with these effects being ad-
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Figure 4 Pedigrees of the 20 participating families. Index patients with breast cancer are represented by blackened circles. Numbers within
the symbols are scores in the assay; results of repeat tests are given as two or three numbers within a symbol. For index cases for which there
are two or three numbers, the upper value is for preradiotherapy testing, and the lower value(s) is(are) posttherapy. Sensitive responses are in
boldface; normal responses in italics. In order to anonymize the pedigrees, we have not included ages of family members, regardless of whether
they are alive or whether the family has cancers other than that in the index case.
ditive. Thus, again, the alleles act in a codominant man-
ner, with heterozygote expression. However, only the
double heterozygote is well estimated by the data set,
so the nature of the interaction between the two putative
genes is not well determined. The two-gene model ac-
counts for some 91% of the variance in radiosensitivities
between family members.
The analysis using the various single-gene models was
repeated, excluding the four families in which both pu-
tative genes were segregating (the four outliers above).
Very similar results were obtained, with no evidence for
non-Mendelian transmission once these families had
been excluded, again indicating that the mode of inher-
itance is Mendelian once the effects of the second gene
have been accounted for.
Cancer Risk
Cancer frequencies in the 16 families with elevated
radiosensitivity did not suggest a high-penetrance sus-
ceptibility to breast cancer or other cancers in any family.
Three cases of breast cancer were observed in 18 first-
and second-degree female relatives, the expected number
being 1.35.
Discussion
Our results provide clear evidence of heritability of
chromosomal radiosensitivity of G2 lymphocytes in fam-
ilies in which there is a case of breast cancer. Earlier
studies of small numbers of female-only blood relatives
of patients with breast cancer showed that, on average,
they were more chromosomally radiosensitive than were
normal controls without a family history of breast can-
cer. However, these studies did not address the question
of heritability by examining the segregation of sensitivity
within families (Parshad et al. 1996; Patel et al. 1997;
Helzlouer et al. 1996). Helzlouer et al. (1995) investi-
gated heritability in just one family, in which four of six
Table 3
Model Parameters from Segregation Analysis of G2 Radiosensitivity in 20 Families
Model 1: General
Transmission
and Polygenes
Model 2:
Major-Gene Only
Model 3:
Sporadic
Model 4:
Polygene Only
Model 5: Major-
Environmental Only
Model 6: Major
Gene  Polygene
Model 7:
Major-Gene-Only,
Non-Mendelian
Model 8: General-
Transmission Only
Allele frequency, p .96 .96 NA NA .77 .96 .98 .94
Means:
nn 4.48 4.48 4.63 4.67 4.48 4.48 4.48 4.47
ns 4.85 4.85 NA NA 4.81 4.84 4.85 4.81
ss 5.27 5.27 NA NA 5.17 5.30 5.28 5.18
Residual SD .101 .101 .23 .21 .077 .10 .10 .077
Polygene heritability, H 0a [0] NA .79 [0] .30 [0] [0]
Genotype-transmission probabilities:b
t1 .96 [1] NA NA [p] [1] [1] .96
t2 .37 [.5] NA NA [p] [.5] .35 .37
t3 .29 [0] NA NA [p] [0] [0] .29
2 # Log likelihood 76.6 68.5 9.8 18.1 50.8 71.2 71.4 76.6
No. of fitted parameters 9 5 2 3 5 6 6 8
Likelihood-ratio x2-test P values:
Compared with model 1 NA .090 !.001 !.001 !.001 .15 .16 1.0
Compared with model 2 .090 NA !.001 NA NA .11 .087 .045
NOTE.—NA = not applicable. Parameters in square brackets were held fixed in the model.
a Fitted parameter value at its lowest boundary.
b t1, t2, and t3 take values of 1, .5, and 0, respectively, for Mendelian inheritance (see Subjects and Methods).
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Figure 5 Pedigrees of families 1, 2, and 8, showing putative
genotypes based on the single-gene (in the case of families 1 and 2)
or two-gene (in the case of family 8) models. “n” and “s” denote
alleles that confer a normal or a sensitive response in the assay, re-
spectively; where two putative genes are segregating, the genotypes of
the second gene are italicized; where the symbols are in parentheses,
the genotypes have been inferred. Other symbols are as in figure 4.
sisters had breast cancer. Two of the three affected sisters
who were tested were radiosensitive, and five of seven
first-degree relatives tested also were sensitive. However,
the segregation of sensitivity was non-Mendelian, in that
the affected sister with a normal sensitivity score, who
had a husband who also had a normal score, had a son
who was radiosensitive.
The segregation analysis presented here shows clear
evidence of Mendelian heritability of chromosomal ra-
diosensitivity, the inheritance being dominated by one
or more major genes with large and additive effects. A
single major gene can account for 82% of the radiosen-
sitivity variance between the members of the 20 families;
however, the data are better explained by the inclusion
of a second, rarer gene, but this is largely because of the
poor fit to the single-gene model of one or two individ-
uals in each of three families. Other, more complex ge-
netic mechanisms would probably fit the data as well,
and the mechanisms and genes may differ between
families.
It is rather surprising that a data set of the limited size
presented here is sufficiently powerful to allow us to
detect statistically significant major genes; however there
are three factors that act in our favor: (1) the large phe-
notypic effect of the major genes (with a displacement
value of nearly 8), (2) the lack of any confounding cov-
ariates, and (3) the lack of any detectable environmental
influence. Against this we have to put the intrinsic assay
variability, which will mask any polygenic factors up to
a CV of ∼10%. The large displacement, with good phe-
notypic separation between the normal and sensitive
genotypes, ought to make gene mapping by linkage anal-
ysis relatively straightforward. However, the relative
abundance of the putative gene in the population, along
with the likely presence of multiple genes, will compli-
cate any linkage study. The best approachmay be a study
based on a few large families, but other approaches are
possible.
At present the identity of the putative genes is un-
known. Their characteristics are that they appear to be
involved in the processing of DNA damage of the type
induced by ionizing radiation and that mutants (or var-
iants) are relatively common within the normal popu-
lation (Scott et al. 1994, 1999; Parshad et al. 1996) and
present at high frequency among patients with breast
cancer (Scott et al. 1994, 1999; Parshad et al. 1996;
Patel et al. 1997). We predict that they lead to breast-
cancer predisposition at a low level of penetrance. Pos-
sible candidates are rare microsatellite variants (poly-
morphisms) associated with XRCC DNA-repair genes.
Mutations within the XRCC genes confer cellular ra-
diosensitivity, and Price et al. (1997) have found that
the frequency of rare microsatellite polymorphisms is
very high (58% [11/19 cases]) among patients with can-
cer (including breast cancer) and absent from 34 healthy
controls. Minisatellite variants associated with the H-
ras-1 proto-oncogene have been implicated as low-pen-
etrance breast cancer–predisposing genes in ∼10% of
cases, and it has been suggested that these variants might
disrupt the controlled expression of the H-ras-1 gene
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Table 4
Genotype Values for the Two-Gene Model
GENE 1 (FREQUENCY 6.5%)
GENE 2 (FREQUENCY 1.8%)a
Null Heterozygote Homozygote
Null 4.47  .01 4.82  .03 5.03  .28
Heterozygote 4.79  .03 5.11  .04 [5.05  .67]
Homozygote 5.27  .05 [4.54  .19] [5.08  2.45]
a Data in square brackets are for genotypes predicted to occur with a frequency less than once in
the data set and that therefore are poorly determined.
(Krontiris et al. 1993); however, known mutations inH-
ras-1 either have no influence on cellular radiosensitivity
(Su and Little 1992) or confer radioresistance (Bernhard
et al. 1998). It seems unlikely, therefore, that the radi-
osensitive individuals identified in our study will be car-
riers of these predisposing minisatellite variants. Only a
small proportion of these radiosensitive individuals are
likely to be A-T heterozygotes (see the Introduction sec-
tion, above).
In this study we did not attempt to determine an ac-
curate or complete family history of cancer. The limited
information obtained from interviewing the probands
did not indicate any dramatic history of cancer within
the families. The relative risk of breast cancer was only
two- to threefold greater than that in controls, with the
numbers of cases being too small for statistical analysis.
In our earlier work (Scott et al. 1999), a comparison of
the numbers of patients and controls who were sensitive
in the assay would suggest an increased (approximately
fivefold) lifetime breast-cancer risk associated with the
radiosensitive phenotype. However, in that study the
populations of cases and controls were not sufficiently
well matched, and the study size was not large enough
to allow us to accurately determine the odds ratio. There
is a clear need for much larger, carefully planned epi-
demiological studies to quantify the risk for “sensitive”
individuals and their relatives. The current, crude, risk
estimates suggest that the radiosensitive genotypes con-
fer a cancer risk similar to that seen in the A-T heter-
ozygotes (who have a similar sensitivity in the assay
[Scott et al. 1994]), in whom there is reported to be a
fourfold-increased cancer risk (Easton 1994) but no sig-
nificant family history of cancer (Bishop and Hopper
1997).
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